| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GPL21103
|
GSE203190
|
|||||||
| GSM6161317 |
T1 - Naïve Trp1 CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161318 |
T2 - Naïve Trp1 CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161319 |
T3 - Naïve Trp1 CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161320 |
T4 - Tumor Trp1 CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161321 |
T5 - Tumor Trp1 CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161322 |
T6 - Tumor Trp1 CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161323 |
T7 - Tumor Trp1 CD4+CD8+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161324 |
T8 - Tumor Trp1 CD4+CD8+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161325 |
T9 - Tumor Trp1 CD4+CD8+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161326 |
P1 - Naïve Pmel CD8+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161327 |
P2 - Naïve Pmel CD8+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161328 |
P3 - Naïve Pmel CD8+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161329 |
P4 - Tumor Pmel CD8+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161330 |
P5 - Tumor Pmel CD8+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161331 |
P6 - Tumor Pmel CD8+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161332 |
P7 - Tumor Pmel CD8+CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161333 |
P8 - Tumor Pmel CD8+CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161334 |
P9 - Tumor Pmel CD8+CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161338 |
T1 - ATAC-Seq - Naïve Trp1 CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 | ||
| GSM6161339 |
T2 - ATAC-Seq - Naïve Trp1 CD4+
|
SRA | 1 |
|
|
Bic MSKCC | May 20, 2022 |
